Related Experiment Videos
Novel factor X deficiency. Normal partial thromboplastin time and associated spindle cell thymoma
The American Journal of Medicine
|July 1, 1985
Summary
This study details a novel laboratory variant of congenital factor X deficiency, a rare bleeding disorder, identified alongside a rare tumor. Unique management strategies were needed for the patient's coagulopathy.
Area of Science:
- Hematology
- Clinical Pathology
- Oncology
Background:
- Congenital factor X deficiency is a rare inherited bleeding disorder.
- Coagulopathy management presents unique challenges in patients with rare comorbidities.
Observation:
- A patient presented with a history of bleeding and prolonged prothrombin time.
- Laboratory tests revealed a factor X activity of 4.2% of normal.
- Partial thromboplastin time and Russell's viper venom clotting time were within normal limits.
Findings:
- A previously undescribed laboratory variant of congenital factor X deficiency was identified.
- The deficiency was observed in conjunction with a rare tumor, suggesting a potential link.
- This specific variant presented with a unique coagulation profile.
Implications:
- This case highlights the importance of comprehensive coagulation testing in diagnosing rare bleeding disorders.
- The findings necessitate the development of tailored management strategies for complex coagulopathies.
- Further research may elucidate the relationship between factor X deficiency variants and specific tumor types.